Marotta Asset Management Reduces Stock Position in The Procter & Gamble Company (NYSE:PG)

Marotta Asset Management lowered its stake in shares of The Procter & Gamble Company (NYSE:PG) by 11.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,486 shares of the company’s stock after selling 194 shares during the period. Marotta Asset Management’s holdings in Procter & Gamble were worth $247,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Itau Unibanco Holding S.A. bought a new position in shares of Procter & Gamble during the 2nd quarter valued at about $28,000. Fairway Wealth LLC purchased a new position in shares of Procter & Gamble during the second quarter worth approximately $29,000. RPg Family Wealth Advisory LLC bought a new position in shares of Procter & Gamble during the 3rd quarter valued at $33,000. Quest Partners LLC bought a new stake in Procter & Gamble in the second quarter worth $36,000. Finally, Fairfield Financial Advisors LTD purchased a new stake in Procter & Gamble during the second quarter valued at about $44,000. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Stock Performance

NYSE PG traded down $2.39 on Friday, reaching $159.71. 1,780,319 shares of the company’s stock traded hands, compared to its average volume of 5,707,951. The stock has a 50 day moving average price of $169.77 and a 200-day moving average price of $169.64. The firm has a market cap of $376.12 billion, a price-to-earnings ratio of 27.54, a P/E/G ratio of 3.70 and a beta of 0.45. The Procter & Gamble Company has a fifty-two week low of $146.28 and a fifty-two week high of $180.43. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business’s revenue for the quarter was down .6% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.83 EPS. Equities research analysts predict that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Wells Fargo & Company lowered their price target on shares of Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a research report on Tuesday. DA Davidson reiterated a “buy” rating and issued a $209.00 target price on shares of Procter & Gamble in a research note on Friday, December 27th. Piper Sandler began coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. Royal Bank of Canada restated a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a research note on Monday, October 21st. Finally, Morgan Stanley lifted their target price on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Eight research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and an average target price of $179.75.

Insider Buying and Selling

In other Procter & Gamble news, CEO R. Alexandra Keith sold 1,992 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the sale, the chief executive officer now directly owns 13,783 shares of the company’s stock, valued at approximately $2,343,110. The trade was a 12.63 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of the company’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the transaction, the chief executive officer now owns 39,977 shares of the company’s stock, valued at $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 75,439 shares of company stock worth $13,317,460 over the last 90 days. 0.18% of the stock is owned by insiders.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.